{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:51:22Z","timestamp":1785894682318,"version":"3.56.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["T32 ES007255"],"award-info":[{"award-number":["T32 ES007255"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DA053047"],"award-info":[{"award-number":["R01 DA053047"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DA047180"],"award-info":[{"award-number":["R01 DA047180"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jpet.2026.104952","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T06:51:40Z","timestamp":1779864700000},"page":"104952","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Inflammasome formation and interleukin-1\u03b2 secretion are reduced in peripheral blood monocytes from HIV+ cannabis users"],"prefix":"10.1016","volume":"393","author":[{"given":"Brianna M.","family":"Finn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sera","family":"Sermet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Gulick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert E.","family":"Kaminski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpet.2026.104952_bib1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/1741-7015-11-251","article-title":"Do people with HIV infection have a normal life expectancy in the era of combination antiretroviral therapy?","volume":"11","author":"Sabin","year":"2013","journal-title":"BMC Med"},{"issue":"9053","key":"10.1016\/j.jpet.2026.104952_bib2","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0140-6736(96)10178-1","article-title":"Unique monocyte subset in patients with AIDS dementia","volume":"349","author":"Pulliam","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jpet.2026.104952_bib3","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.3389\/fmicb.2019.01104","article-title":"Gut Microbiome alterations during HIV\/SIV infection: implications for HIV cure","volume":"10","author":"Crakes","year":"2019","journal-title":"Front Microbiol"},{"issue":"4","key":"10.1016\/j.jpet.2026.104952_bib4","first-page":"1113","article-title":"HIV-associated neurocognitive disorder (HAND) and the prospect of brain-penetrating protease inhibitors for antiretroviral treatment","volume":"5","author":"Ghosh","year":"2017","journal-title":"Med Res Arch"},{"issue":"3","key":"10.1016\/j.jpet.2026.104952_bib5","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1212\/CPJ.0000000000000117","article-title":"HIV-associated neurocognitive disorders: five new things","volume":"5","author":"Rumbaugh","year":"2015","journal-title":"Neurol Clin Pract"},{"issue":"4","key":"10.1016\/j.jpet.2026.104952_bib6","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.immuni.2013.10.001","article-title":"Systemic effects of inflammation on health during chronic HIV infection","volume":"39","author":"Deeks","year":"2013","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.jpet.2026.104952_bib7","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/nm1511","article-title":"Microbial translocation is a cause of systemic immune activation in chronic HIV infection","volume":"12","author":"Brenchley","year":"2006","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.jpet.2026.104952_bib8","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/nrmicro2848","article-title":"Microbial translocation in HIV infection: causes, consequences and treatment opportunities","volume":"10","author":"Sandler","year":"2012","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"10.1016\/j.jpet.2026.104952_bib9","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.tim.2012.09.001","article-title":"Microbial translocation, immune activation, and HIV disease","volume":"21","author":"Klatt","year":"2013","journal-title":"Trends Microbiol"},{"issue":"3","key":"10.1016\/j.jpet.2026.104952_bib10","first-page":"167","article-title":"Bacterial lipopolysaccharides and innate immunity","volume":"7","author":"Alexander","year":"2001","journal-title":"J Endotoxin Res"},{"issue":"5","key":"10.1016\/j.jpet.2026.104952_bib11","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1615\/CritRevImmunol.v31.i5.20","article-title":"LPS-induced cytokine production in human monocytes and macrophages","volume":"31","author":"Rossol","year":"2011","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.jpet.2026.104952_bib12","article-title":"Mice plasmacytoid dendritic cells were activated by lipopolysaccharides through toll-like receptor 4\/myeloid differentiation factor 2","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.jpet.2026.104952_bib13","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/jleuko\/qiad017","article-title":"Of mice, or men: TLR4 signaling in HIV pathogenesis","volume":"113","author":"Acosta","year":"2023","journal-title":"J Leukoc Biol"},{"issue":"1\u20133","key":"10.1016\/j.jpet.2026.104952_bib14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12026-012-8297-3","article-title":"The three human monocyte subsets: implications for health and disease","volume":"53","author":"Wong","year":"2012","journal-title":"Immunol Res"},{"issue":"3","key":"10.1016\/j.jpet.2026.104952_bib15","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1189\/jlb.0806510","article-title":"The CD14+ CD16+ blood monocytes: their role in infection and inflammation","volume":"81","author":"Ziegler-Heitbrock","year":"2007","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jpet.2026.104952_bib16","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/569819","article-title":"Monocytes as regulators of inflammation and HIV-related comorbidities during cART","volume":"2014","author":"Anzinger","year":"2014","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jpet.2026.104952_bib17","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.3389\/fimmu.2019.01435","article-title":"The HIV reservoir in monocytes and macrophages","volume":"10","author":"Wong","year":"2019","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.jpet.2026.104952_bib18","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1080\/135502801753248114","article-title":"CNS invasion by CD14+\/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection","volume":"7","author":"Fischer-Smith","year":"2001","journal-title":"J Neurovirol"},{"key":"10.1016\/j.jpet.2026.104952_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2019.576969","article-title":"Imiquimod and interferon-alpha augment monocyte-mediated astrocyte secretion of MCP-1, IL-6 and IP-10 in a human co-culture system","volume":"333","author":"Rizzo","year":"2019","journal-title":"J Neuroimmunol"},{"issue":"1","key":"10.1016\/j.jpet.2026.104952_bib20","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1124\/jpet.119.260661","article-title":"\u03949-Tetrahydrocannabinol suppresses monocyte-mediated astrocyte production of monocyte chemoattractant protein 1 and interleukin-6 in a toll-like receptor 7-stimulated human coculture","volume":"371","author":"Rizzo","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"issue":"105","key":"10.1016\/j.jpet.2026.104952_bib21","article-title":"Interleukin-1beta (IL-1beta) processing pathway","volume":"3","author":"Weber","year":"2010","journal-title":"Sci Signal"},{"issue":"2","key":"10.1016\/j.jpet.2026.104952_bib22","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","article-title":"The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta","volume":"10","author":"Martinon","year":"2002","journal-title":"Mol Cell"},{"issue":"7","key":"10.1016\/j.jpet.2026.104952_bib23","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2016.58","article-title":"Inflammasomes: mechanism of assembly, regulation and signalling","volume":"16","author":"Broz","year":"2016","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"10.1016\/j.jpet.2026.104952_bib24","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1097-2765(00)80032-5","article-title":"Autoproteolytic activation of pro-caspases by oligomerization","volume":"1","author":"Yang","year":"1998","journal-title":"Mol Cell"},{"issue":"1","key":"10.1016\/j.jpet.2026.104952_bib25","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41421-020-0167-x","article-title":"Inflammasome activation and regulation: toward a better understanding of complex mechanisms","volume":"6","author":"Zheng","year":"2020","journal-title":"Cell Discovery"},{"issue":"3","key":"10.1016\/j.jpet.2026.104952_bib26","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1089\/can.2018.0068","article-title":"Cannabis consumption in people living with HIV: reasons for use, secondary effects, and opportunities for health education","volume":"4","author":"Costiniuk","year":"2019","journal-title":"Cannabis Cannabinoid Res"},{"issue":"1","key":"10.1016\/j.jpet.2026.104952_bib27","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1155\/2014\/301713","article-title":"Patterns and correlates of cannabis use among individuals with HIV\/AIDS in Maritime Canada","volume":"25","author":"Harris","year":"2014","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"2","key":"10.1016\/j.jpet.2026.104952_bib28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1521\/aeap.2018.30.2.169","article-title":"Frequency of cannabis use and medical cannabis use among persons living with HIV in the United States: findings from a nationally representative sample","volume":"30","author":"Pacek","year":"2018","journal-title":"AIDS Educ Prev"},{"issue":"2","key":"10.1016\/j.jpet.2026.104952_bib29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1300\/J175v03n02_02","article-title":"Cannabis use by persons living with HIV\/AIDS: patterns and prevalence of use","volume":"3","author":"Ware","year":"2003","journal-title":"J Cannabis Ther"},{"issue":"1","key":"10.1016\/j.jpet.2026.104952_bib30","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1089\/can.2018.0073","article-title":"Immune responses regulated by cannabidiol","volume":"5","author":"Nichols","year":"2020","journal-title":"Cannabis Cannabinoid Res"},{"issue":"4\u20135","key":"10.1016\/j.jpet.2026.104952_bib31","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000481824","article-title":"Immunoregulatory role of cannabinoids during infectious disease","volume":"24","author":"Hern\u00e1ndez-Cervantes","year":"2017","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.jpet.2026.104952_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2021.153016","article-title":"Cannabidiol selectively modulates interleukin (IL)-1\u03b2 and IL-6 production in toll-like receptor activated human peripheral blood monocytes","volume":"464","author":"Sermet","year":"2021","journal-title":"Toxicology"},{"issue":"14","key":"10.1016\/j.jpet.2026.104952_bib33","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.3390\/ijms21145064","article-title":"Targeting cannabinoid receptors: current status and prospects of natural products","volume":"21","author":"An","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10.1016\/j.jpet.2026.104952_bib34","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1002\/cbdv.200790152","article-title":"Human cannabinoid pharmacokinetics","volume":"4","author":"Huestis","year":"2007","journal-title":"Chem Biodivers"},{"key":"10.1016\/j.jpet.2026.104952_bib35","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bcp.2018.08.046","article-title":"Cannabidiol skews biased agonism at cannabinoid CB1 and CB2 receptors with smaller effect in CB1-CB2 heteroreceptor complexes","volume":"157","author":"Navarro","year":"2018","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jpet.2026.104952_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1634203","article-title":"Cannabis use is associated with alterations in NLRP3 inflammasome related gene expression in monocyte-derived macrophages from people living with HIV","volume":"16","author":"Walter","year":"2025","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.jpet.2026.104952_bib37","doi-asserted-by":"crossref","first-page":"455","DOI":"10.4049\/jimmunol.1401110","article-title":"A novel flow cytometric method to assess inflammasome formation","volume":"194","author":"Sester","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.jpet.2026.104952_bib38","doi-asserted-by":"crossref","first-page":"8761","DOI":"10.1038\/ncomms9761","article-title":"Human caspase-4 and caspase-5 regulate the one-step non-canonical inflammasome activation in monocytes","volume":"6","author":"Vigan\u00f2","year":"2015","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.jpet.2026.104952_bib39","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.4049\/jimmunol.2000373","article-title":"Function and regulation of noncanonical caspase-4\/5\/11 inflammasome","volume":"204","author":"Matikainen","year":"2020","journal-title":"J Immunol"},{"key":"10.1016\/j.jpet.2026.104952_bib40","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1146\/annurev-immunol-031210-101405","article-title":"The inflammasome NLRs in immunity, inflammation, and associated diseases","volume":"29","author":"Davis","year":"2011","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jpet.2026.104952_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.702527","article-title":"Updating the NLRC4 inflammasome: from bacterial infections to autoimmunity and cancer","volume":"12","author":"Wen","year":"2021","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.jpet.2026.104952_bib42","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/imr.12607","article-title":"The NLRC4 inflammasome","volume":"281","author":"Duncan","year":"2018","journal-title":"Immunol Rev"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526011511?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526011511?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:32:13Z","timestamp":1785893533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356526011511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0022356526011511"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2026.104952","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammasome formation and interleukin-1\u03b2 secretion are reduced in peripheral blood monocytes from HIV+ cannabis users","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2026.104952","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"104952"}}